CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Doxycyclinedrug
Likely dose
Doxycycline 40 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01469585
NCT01469585N/ACompleted
CompareCT.gov

Oral Contraceptives and Subantimicrobial Doxycycline: Effect on Endometrial Matrix Metalloproteinases

University of Hawaii·interventional·Posted Nov 10, 2011·Updated Dec 17, 2020

In Brief

A clinical study evaluating Doxycycline for Breakthrough Bleeding. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The purpose of this study is to compare the effects (good and bad) of subantimicrobial dose doxycycline on the irregular bleeding women experience when taking continuous oral contraceptive pills. This research is being done because currently, there is no effective treatment for this condition. Findings from this study could help to decrease the side effects of birth control pills and decrease unplanned pregnancies.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreakthrough Bleeding
CountriesUnited States
CollaboratorsCharles Drew University of Medicine and Science, Meharry Medical College

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedNov 10, 2011
Enrollment StartNov 1, 2011
Primary CompletionMay 1, 2012
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 14.6 years ago

Interventions

Doxycyclinedrug

40 mg orally at the start of cycle 3 (study day 57) for 28 days.